CHMP2B Mutations are Rare in French Families with Frontotemporal Lobar Degeneration.‎
Publication Type
Original research
Authors
  • M. Ghanim
  • L. Guillot-Noel
  • L. Jornea
  • B. Dubois
  • I. Le Ber
  • A. Brice
  • F. Pasquier
  • V. Deramecourt
Fulltext
Download

Two C-truncating CHMP2B (chromatin modifying protein 2B) mutations were recently found in Danish and Belgian families with autosomal dominant forms of frontotemporal lobar degeneration (FTLD). In addition, few CHMP2B missense mutations of uncertain pathogenic role were reported in several families with FTLD or FTLD associated with motoneuron disease (FTLD-MND). In order to determine the genetic contribution of CHMP2B mutations in FTLD and FTLD-MND families, we analyzed the CHMP2B gene in 198 French probands with familial FTLD and FTLD-MND. One CHMP2B missense variant was found in a proband with familial FTLD (0.8%). The pathogenic role of CHMP2B missense variants is unclear, however the pSer194Leu substitution, located in the C-terminal domain of the protein, was predicted to alter the stability of the protein by in silico analyses. We conclude that CHMP2B mutations represent a rare cause of familial FTLD and they are not implicated in familial FTLD-MND in French patients. The previously reported C-truncating CHMP2B mutations may be private to the Danish and Belgian pedigrees.

Journal
Title
J Neurol, 257:2032–2036
Publisher
--
Publisher Country
Palestine
Publication Type
Both (Printed and Online)
Volume
--
Year
2010
Pages
--